Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus
| Autor: | Rasha Al-Darraji, Hussein Nafakhi, Alhan Al-Khalidi, Foaad Shaghee, Mohammed Noori Al-Dujaili, Mohammed Alareedh, Karrar Al-Buthabhak, Ahmed Mechi |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry medicine.drug_class Endocrinology Diabetes and Metabolism COVID-19 Acute infection Chest pain medicine.disease Sulfonylurea Short Article Diabetes mellitus Internal medicine Symptoms DM Long term Internal Medicine Persistent cough Medicine In patient medicine.symptom business |
| Zdroj: | International Journal of Diabetes in Developing Countries |
| ISSN: | 1998-3832 0973-3930 |
| DOI: | 10.1007/s13410-021-00994-w |
| Popis: | Objective The study aimed to assess the long-term persistent symptoms of patients with diabetes mellitus (DM) and COVID-19 infection at 9 months after acute infection. Methods This single-center cross-sectional study was conducted from May 20 to June 1, 2021. Results A total of 112 patients were included in the present study. The most frequently reported persistent symptoms among DM group were fatigue (p = 0.01), shortness of breath (p = 0.01), and chest pain (p = 0.02) compared to non-DM group. Sulfonylurea use was associated with persistent cough (p = 0.04). Conclusion Long-term persistent symptoms of COVID-19 infection are common among patients with DM. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink